Ligand-independent Hh signaling has mainly been described in BCC and MB and can either be due to loss-of-function mutations (PTCH1, SUFU) or otherwise caused by gain-of-function mutations (SHH, SMO or GLI1/2). The gene discussed is SMO; the disease is skin basal cell carcinoma.